Research and Markets: Athlete's Foot (Tinea Pedis) - Pipeline Review, H2 2011

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2fec72/athletes_foot_ti) has announced the addition of Global Markets Direct's new report "Athlete's Foot (Tinea Pedis) - Pipeline Review, H2 2011" to their offering.

“Athlete's Foot (Tinea Pedis) - Pipeline Review, H2 2011”

Global Markets Direct's, 'Athlete's Foot (Tinea Pedis) - Pipeline Review, H2 2011', provides an overview of the Athlete's Foot (Tinea Pedis) therapeutic pipeline. This report provides information on the therapeutic development for Athlete's Foot (Tinea Pedis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Athlete's Foot (Tinea Pedis). 'Athlete's Foot (Tinea Pedis) - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources

Scope

• A snapshot of the global therapeutic scenario for Athlete's Foot (Tinea Pedis).
• A review of the Athlete's Foot (Tinea Pedis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Coverage of products based on various stages of development ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
• Coverage of the Athlete's Foot (Tinea Pedis) pipeline on the basis of route of administration and molecule type.
• Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.

Reasons to buy

• Identify and understand important and diverse types of therapeutics under development for Athlete's Foot (Tinea Pedis).
• Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
• Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
• Devise corrective measures for pipeline projects by understanding Athlete's Foot (Tinea Pedis) pipeline depth and focus of Athlete's Foot (Tinea Pedis) therapeutics.

For more information visit http://www.researchandmarkets.com/research/2fec72/athletes_foot_ti